For laboratory research use only. Not for human or veterinary use.
BioIntegrityPeptide Research

Metabolic Signaling

GLP-3R / GLP-1S Agonist Blend

Dual agonist blend

GLP-3 Triple Agonist and GLP-1 blend

Research context

This preparation combines two incretin receptor agonists with differing receptor profiles in a single formulation. Each component is characterised independently in the published literature; the blend itself is supplied as a convenience preparation and has not been separately characterised.

Common assays: Component identity by LC-MS · Purity by RP-HPLC per component

Specification

DesignationDual agonist blend
Full nameGLP-3 Triple Agonist and GLP-1 blend
ComponentsGLP-3 Triple Agonist · GLP-1
Formats15 mL Advanced Liquid Peptide Spray
SolubilitySupplied in metered spray format
StorageRefrigerated 2–8 °C, protected from light
Current lotRS4025N1125 →

GLP-3R / GLP-1S Agonist Blend COA: certificates of analysis by lot

One lot of GLP-3R / GLP-1S Agonist Blend has a published certificate of analysis from AxisPharm, LLC, an independent laboratory. Each certificate reports the laboratory's results for that lot.

LotFormatPurity (HPLC-UV)Reported
RS4025N112525 mg / 40 mg Spray>99.0%2025-11-24

Common questions

How are blend products verified analytically?

Each component is identified and quantified separately by LC-MS and RP-HPLC. The certificate reports results per component rather than as a single combined figure.

Where can I see the GLP-3R / GLP-1S Agonist Blend certificate of analysis?

Every published GLP-3R / GLP-1S Agonist Blend lot has its own certificate page on this site, listed under "GLP-3R / GLP-1S Agonist Blend COA" above. There is one published lot; the most recent, lot RS4025N1125, was reported on 2025-11-24 at >99.0% purity by HPLC-UV. The certificates are issued by AxisPharm, LLC, an independent laboratory.

Components, blends and pathway

Related compounds